A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, ...

Men from the placebo group whose PSA had never exceeded 4.0 ng/ml, who had never previously undergone a prostate biopsy or transurethral prostate resection, and who had consistently normal results ...

Some of the risks of prostate screening include the false positive rate. The false positive rate is the number of men with an abnormal PSA, who do not have cancer. For some years a cutoff of 4.0 ng/mL ...

Prostate-specific antigen (PSA) is a protein the prostate produces from both normal and abnormal cells. The prostate is a ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Screening PSA levels at aged 65-69 may inform the decision to continue or discontinue prostate cancer screening after age 70 years, regardless of patient race and ethnicity. The absolute risks of ...

In summary, when an asymptomatic man presents with a modestly elevated PSA level (<10 ng/ml) and a normal digital rectal examination, the most appropriate recommendation is to reassure the patient ...

It can help them see how well treatment is working. Prostate specific antigen (PSA) is a protein produced by both normal and cancerous prostate cells. It's normal for all men to have some PSA in their ...

Atsushi Tomioka; Nobumichi Tanaka; Motokiyo Yoshikawa; Makito Miyake; Satoshi Anai; Yoshitomo Chihara; Eijiro Okajima; Akihide Hirayama; Yoshihiko Hirao; Kiyohide Fujimoto There are limitations to ...

Singer et al. found that regular consumption of either of these agents lowers serum PSA levels, which indicate prostate injury and are believed to predict the risk of developing prostate cancer.

There is no national screening programme for prostate cancer in the UK. This is because there isn’t a reliable test that can pick up prostate cancer that needs treatment at an early stage. Researchers ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...